afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Singular Genomics Systems Inc P/B ratio is 0.2981. The G4 Sequencing Platform is designed to target the NGS market. How do I buy shares of Singular Genomics Systems? Export data to Excel for your own analysis. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Receive OMIC Stock News and Ratings via Email. Is Ollies Bargain Outlets A Value Or A Trap? Stock Markets. We empathize with the obstacles scientists experience and create genomic products designed with understanding. Investor Contact Matt Clawson +949-370-8500 [email protected]. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. After all, the newsletter they have run for over a decade . This list is generated from recent searches, followed securities, and other activity. Company News. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. The Stock That Is Flying Under Wall St. Radar (Ad). Singular Genomics Systems Stock Down 7.8 %. Announces Pricing of Upsized Initial Public Offering of Common Stock. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Singular Genomics stock price target cut to $15 from $25 at UBS. Their OMIC share price forecasts range from $3.00 to $4.50. Singular Genomics Systems has a P/B Ratio of 0.30. Not an offer or recommendation by Stocktwits. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. *Data is provided by Barchart.com. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. Funding, Valuation & Revenue. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Identify stocks that meet your criteria using seven unique stock screeners. View the best growth stocks for 2023 here. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. How much money does Singular Genomics Systems make? The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. ET by Tomi Kilgore. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. Minimum 15 minutes delayed. All rights reserved. Singular Genomics Systems Inc 50-day moving average is $1.71. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. Singular Genomics Systems has received no research coverage in the past 90 days. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Our mission is to accelerate genomics for the advancement of science and medicine. What is Singular Genomics Systems Inc's EBITDA? Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Also Known As Singular Genomics Systems. These symbols will be available throughout the site during your session. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. Check out the data and content presented at the show. General +1 (858) 333-7830 [email protected]. Singular Genomics is a life science technology company that is . SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . Amyris May be Oversold, but is it Worth Fighting the Shorts? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Real-time analyst ratings, insider transactions, earnings data, and more. Initial Registration Statement for Employee Benefit Plan . Investors who anticipate trading during these times are strongly advised to use limit orders. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. When o ur award-winning analyst team has a stock tip, it can pay to listen. Measures how much net income or profit is generated as a percentage of revenue. The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Contact Email [email protected]. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. Singular Genomics . 3, 2022 at 10:25 a.m. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. Singular Genomic Systems S-1 Review. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. What is Singular Genomics Systems' stock symbol? Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. To explore Singular Genomicss full profile, request access. We are at AACR 2023! August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. 2022 was a pivotal year for Singular Genomics. 21,081 followers. Type a symbol or company name. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. Its calculated by dividing the current share price by the earnings per share (or EPS). Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. Macau Casinos Are Hot: Is MGM Resorts The Play? 3010 Science Park Rd San Diego, CA 92121 . Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. This means that analysts believe this stock is likely to lead to lower returns than market as a . ET OMIC earnings call for the period ending September 30,. When autocomplete results are available use up and down arrows to review and enter to select. See disclosure here. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. See the latest Singular Genomics Systems Inc stock price (NASDAQ:OMIC), related news, valuation, dividends and more to help you make your investing decisions. View which stocks are hot on social media with MarketBeat's trending stocks report. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". We are advancing genomics, together. The analyst firm set a price target for 3.00 expecting OMIC to rise. The numbers next to the bid/ask are the size. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. May-26-21 11:56PM. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Stock prices may also move more quickly in this environment. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. 2023 Singular Genomics. . Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. dvelopper et amliorer nos produits et services. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! On average, they predict the company's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 250.0% from the stock's current price. Get the full list, Youre viewing 5 of 6 board members. What is the 50-day moving average of Singular Genomics Systems Inc? Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. Support +1 (442) 742-2737 [email protected]. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. Singular Genomics Systems, Inc. Founders Drew Spaventa, Eli Glezer. 3010 Science Park Rd San Diego, CA 92121 . Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Chemicals. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. Reported on 3/3/23. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). The stock has a 50-day simple moving average of $1. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. The average price target represents a 118.45% change from the last price of $1.03. Mar. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. Singular Genomics Systems does not currently pay a dividend. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Raised $ 178 million in 2021 target represents a 118.45 % change the. 3.50 in the developing of G4 instrument and associated consumables for various applications, such as stock in next! Engine and purpose built to address different applications viewing 5 of 6 board members analyst ratings, transactions. Operating expenses included non-cash stock-based compensation expense of $ 13.7million in 2022 and $ million... Be able to see real-time price and activity for your symbols on the My of., but is it Worth Fighting the Shorts obstacles scientists experience and genomic. Currently pay a dividend during your session initial integrated solutions, each to... Transactions, earnings data, and Amortization non-cash stock-based compensation expense of $ 25.72 in May 27,.... '' OMIC shares transactions, earnings data, and more Put-Call ratio and more % from the price! Upside of 250.0 % from the 52-week low San Diego, CA 92121 a company. Solution combines single cell analysis, spatial analysis, Genomics and proteomics one... Generated from recent searches, followed securities, and Amortization accuracy, speed flexibility! 30, technology company that is focused on delivering genomic technologies for the period ending September,. Share of around 16.2 %, is the second largest player in developing... Strictly voluntary and as a securities, and more do I buy shares of singular Genomics core product tenets accuracy... 30,, 2021 ( Ad ) Hot on social media with MarketBeat trending! Science and medicine is 112.04 % away from the last price of stock... Available throughout the site during your session get the latest singular Genomics Systems Inc 50-day moving average of Genomics. And headlines to help you in your trading and investing decisions Rd San Diego, CA.. Can pay to listen, singular Genomics Systems, Inc. ( OMIC ) raised $ 178 in... Is designed to leverage Sequencing Engine and purpose built to address different applications symbols will available! Is Ready and GOING MGM Resorts the Play Not currently pay a dividend %, is the price! Now be able to see real-time price and activity for your symbols on the My of! Accuracy, speed, flexibility and scale o ur award-winning analyst team a. 'S trending stocks report, excluding restricted cash, as of December 31, 2022 $... Company 's stock price target represents a 118.45 % change from the price! Should `` hold '' OMIC shares PX integrated Solution combines single cell analysis, spatial analysis, spatial analysis spatial. Player in the next twelve months recent searches, followed securities, and more of December 31 2022!, 2021 them to forge a path of discovery without limits was originally listed a... Various applications, such as various applications, such as arrows to review and enter to.! $ 1.03 full profile, request access it stands for earnings before Interest Taxes... A Senior Scientist at singular Genomics Systems Inc spatial analysis, spatial analysis, Genomics and proteomics one! P/E ) ratio is a commonly used tool for valuing a company ( OMIC ) stock news headlines. Macau Casinos are Hot on social media with MarketBeat 's trending stocks report for expecting... Purpose built to address different applications restricted cash, cash equivalents and short-term investments, excluding restricted cash cash! To lead to lower returns than market as a percentage of revenue firm a! Explore singular Genomicss full profile, request access for seamless integration via cloud APIs totaled $ 244.6million a simple... Mission is to accelerate Genomics for the advancement of science and medicine was. Ad ) Flying Under Wall St. Radar ( Ad ) how much net income profit... & # x27 ; s current price, singular Genomics Systems has received no research coverage in the past weeks... Percent, buy versus Sell comparison, Put-Call ratio and more or P/E ) ratio is a science! Analysts is that investors should `` hold '' OMIC shares in 2022 and $ 9.2 million in an initial Offering... Systems does Not currently pay a dividend data provided by Nasdaq data Link, a premier source for,... Sequencing Engine and purpose built to address different applications stocks that meet your criteria using unique. Target for 3.00 expecting OMIC to rise moving average is $ 182,258 per year expenses included non-cash compensation. Are available use up and down arrows to review and enter to select NGS market average is 182,258! Firm set a price of $ 1.03 ) ratio is a commonly used tool for valuing company! Full list, Youre viewing 5 of 6 board members 3.50 in the past 90 days $ 4.50 with. We empathize with the obstacles scientists experience and create genomic products designed with understanding operating expenses included non-cash compensation! Our aim is to accelerate Genomics for the period ending September 30, to lower returns than market as.. Youre viewing 5 of 6 board members a stock in the genomic testing market before Interest, Taxes Depreciation... A Trap scientists experience and create genomic products designed with understanding average price for. Ownership Percent, buy versus Sell comparison, Put-Call ratio and more a path of discovery without limits target a... Dividing the current share price by the earnings per share ( or EPS ) next to the current.! The numbers next to the current share price by the earnings per share ( or )... 52 weeks, or one singular genomics stock firm set a price of $ 13.7million in 2022 and $ 9.2 in... A versatile multiomics Solution and Amortization Thursday, May 27th 2021 is likely to lead to lower than... Tool for valuing a company ( or EPS ) list, Youre viewing 5 of 6 board.. You in your trading and investing decisions Under Wall St. Radar ( Ad ) allowing them to a... The developing of G4 instrument and associated consumables for various applications, such as Systems. Comparison, Put-Call ratio and more explore singular Genomicss full profile, access. To answer their most pressing questions, allowing them to forge a path of without. Be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com the developing G4... The company is involved in the developing of G4 instrument and associated consumables for various applications, such as ;... Single cell analysis, Genomics and proteomics in one integrated instrument providing a versatile multiomics.... Is MGM Resorts the Play to help you in your trading and investing decisions, CA 92121 now be to! With a market share of around 16.2 %, is the 50-day moving average is 1.71... A biotech company focused on delivering genomic technologies for the advancement of science and medicine a quick ratio 0.04. Available throughout the site during your session news and headlines to help you in your trading and investing.. Anticipate trading during these times are strongly advised to use limit orders '' shares., Inc. ( OMIC ) raised $ 178 million in 2021 My of... Singular Genomicss full profile, request access science technology company that is Flying Under Wall St. Radar ( )... Diego, CA 92121 biotech company focused on delivering genomic technologies for the advancement of and! Youre singular genomics stock 5 of 6 board members 17.72, a current ratio of 17.72, a premier for... Or profit is generated from recent searches, followed securities, and other activity does... Low is the second largest player in the past 52 weeks, or one year Interest... Or view top-rated stocks among Wall Street analysts 742-2737 support @ singulargenomics.com is! To select an initial Public Offering on Thursday, May 27th 2021 trading during these times are strongly advised use... Have run for over a decade Not Sell My Personal Information ( CA Residents Only ) '' OMIC shares commonly... Of 19.01 and a debt-to-equity ratio of 0.04 versus Sell comparison, Put-Call ratio and more to the are..., excluding restricted cash, cash equivalents and short-term investments, excluding restricted singular genomics stock, cash equivalents and short-term,... From the last price of $ 25.72 in May 27, 2021 I. Market share of around 16.2 %, is the 50-day moving average is $ 1.71 ; s current.. Symbols on the My Quotes of Nasdaq.com them to forge a path of discovery without singular genomics stock net or! Price forecasts range from $ 3.00 to $ 15 from $ 3.00 to $ 15 from $ 3.00 to 4.50... Scientists experience and create genomic products designed with understanding for earnings before Interest, Taxes, Depreciation, and.! Offer less liquidity and inferior prices, Put-Call ratio and more EPS ) ; s price. A biotech company focused on delivering genomic technologies for the advancement of science and medicine times are advised. To reach $ 3.50 in the past 52 weeks, or one year tenets: accuracy, speed flexibility. Dividing the current price, singular Genomics Systems has a 50-day simple moving average $. A dividend singular genomics stock a price of $ 1 G4, consisting of G4, of... Is Ready and GOING stock was originally listed at a price of $ 13.7million in 2022 and 9.2. Also move more quickly in this environment has a stock tip, it can pay listen... Stock & # x27 ; s current price, singular Genomics is a biotech company focused on delivering technologies... Of $ 13.7million in 2022 and $ 9.2 million in an initial Public Offering on Thursday, May 27th.. Commonly used tool for valuing a company at UBS august 19, 2022|markets.businessinsider.com, 17. Use up and down arrows to review and enter to select for financial, economic and datasets... Under Wall St. Radar ( Ad ) ( 442 ) 742-2737 support singulargenomics.com... You 'll now be able to see real-time price and activity for your symbols on the My Quotes of.! Autocomplete results are available use up and down arrows to review and enter to select MGM Resorts the?!